Improving the Catalytic CO Reduction on CsAgBiBr by Halide Defect Engineering: A DFT Study
Overview
Affiliations
Pb-free double halide perovskites have drawn immense attention in the potential photocatalytic application, due to the regulatable bandgap energy and nontoxicity. Herein, we first present a study for CO conversion on Pb-free halide perovskite CsAgBiBr under state-of-the-art first-principles calculation with dispersion correction. Compared with the previous CsPbBr, the cell parameter of CsAgBiBr underwent only a small decrease of 3.69%. By investigating the adsorption of CO, CO, NO, NO, and catalytic reduction of CO, we found CsAgBiBr exhibits modest adsorption ability and unsatisfied potential determining step energy of 2.68 eV in catalysis. We adopted defect engineering (Cl doping, I doping and Br-vacancy) to regulate the adsorption and CO reduction behavior. It is found that CO molecule can be chemically and preferably adsorbed on Br-vacancy doped CsAgBiBr with a negative adsorption energy of -1.16 eV. Studying the CO reduction paths on pure and defect modified CsAgBiBr, Br-vacancy is proved to play a critical role in decreasing the potential determining step energy to 1.25 eV. Finally, we probe into the electronic properties and demonstrate Br-vacancy will not obviously promote the process of catalysis deactivation, as there is no formation of deep-level electronic states acting as carrier recombination center. Our findings reveal the process of gas adsorption and CO reduction on novel Pb-free CsAgBiBr, and propose a potential strategy to improve the efficiency of catalytic CO conversion towards practical implementation.
Defects of Metal Halide Perovskites in Photocatalytic Energy Conversion: Friend or Foe?.
Wang C, Xie Z, Wang Y, Ding Y, Leung M, Ng Y Adv Sci (Weinh). 2024; 11(29):e2402471.
PMID: 38828743 PMC: 11304286. DOI: 10.1002/advs.202402471.
Photocatalysis and perovskite oxide-based materials: a remedy for a clean and sustainable future.
Irshad M, Ain Q, Zaman M, Aslam M, Kousar N, Asim M RSC Adv. 2022; 12(12):7009-7039.
PMID: 35424711 PMC: 8982362. DOI: 10.1039/d1ra08185c.